Skip to main content

Latest Articles

Latest Articles

Showing 9 / 872 Weight Management articles

GLP-1s Show Promise in MS, But More Rigorous Research Needed
Multiple Sclerosis

GLP-1s Show Promise in MS, But More Rigorous Research Needed

GLP-1 receptor agonists, originally developed for diabetes, are gaining attention for potential benefits in multiple sclerosis (MS) due to their effects on the brain and metabolic health. Expert Afsaneh Shirani, MD, highlighted promising studies at ACTRIMS, including weight loss and minimal relapses, but stressed the need for more rigorous trials. Key challenges like biomarkers, patient selection, and access remain.

Shotlee··6 min read
Kelly Osbourne's 'Ozempic Face' Photos Alarm Fans Despite Denial
GLP-1 Medications

Kelly Osbourne's 'Ozempic Face' Photos Alarm Fans Despite Denial

Kelly Osbourne stunned fans with her ultra-thin look at the 2026 Grammy Awards, reigniting 'Ozempic face' rumors despite her firm denial of using the drug. After losing 85 pounds through cutting sugar and carbs following gestational diabetes, public skepticism grows amid her skeletal appearance. Discover the story behind the transformation and medical insights on rapid weight loss effects.

Shotlee··6 min read